{"id":11334,"date":"2012-03-30T00:00:00","date_gmt":"2012-03-29T22:00:00","guid":{"rendered":"https:\/\/idibell.cat\/es\/blog\/2012\/03\/30\/fatima-bosch-la-terapia-genica-no-empezo-con-buen-pie-pero-esta-saliendo-del-tunel\/"},"modified":"2022-09-09T16:51:31","modified_gmt":"2022-09-09T14:51:31","slug":"fatima-bosch-la-terapia-genica-no-empezo-con-buen-pie-pero-esta-saliendo-del-tunel","status":"publish","type":"post","link":"https:\/\/idibell.cat\/es\/2012\/03\/fatima-bosch-la-terapia-genica-no-empezo-con-buen-pie-pero-esta-saliendo-del-tunel\/","title":{"rendered":"F\u00e0tima Bosch: \u201cLa terapia g\u00e9nica no empez\u00f3 con buen pie pero est\u00e1 saliendo del t\u00fanel\u201d"},"content":{"rendered":"<p>La directora del <a href=\"http:\/\/cbateg.net\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span class=\"enllac\">Centro de Biotecnolog\u00eda Animal y Terapia G\u00e9nica<\/span><\/a> de la Universidad Aut\u00f3noma de Barcelona, F\u00e0tima Bosch, ha explicado sus \u00faltimas aproximaciones a la terapia g\u00e9nica en una conferencia el 23 de marzo en el ciclo de seminarios del IDIBELL.<\/p>\n<p>El objetivo de la investigaci\u00f3n del centro que dirige Bosch es conocer muy bien la enfermedad y a partir de este conocimiento, buscar dianas terap\u00e9uticas que sirvan para dise\u00f1ar aproximaciones terap\u00e9uticas en terapia g\u00e9nica. Durante el seminario la investigadora ha explicado dos de las aproximaciones en las cuales est\u00e1n trabajando: La diabetes y la mucopolisacaridosis tipo III (MPSIII).<\/p>\n<p>\u201cSon dos aproximaciones totalmente diferentes. Por un lado, la diabetes no la causa un \u00fanico gen y adem\u00e1s debemos buscar una terapia g\u00e9nica que sea mucho m\u00e1s eficiente que los tratamientos que se est\u00e1n usando hasta ahora. En el caso de la MPSIII, se trata de una enfermedad gen\u00e9tica rara por la cual no hay ning\u00fan tratamiento\u201d.<\/p>\n<p>En los dos casos, las terapias g\u00e9nicas han funcionado en modelos animales de ratones y perros y ahora est\u00e1n en proceso de hacer el salto al ensayo cl\u00ednico con humanos. \u201cEl ensayo cl\u00ednico de la MPSIII podr\u00eda empezar la primavera del a\u00f1o pr\u00f3ximo mientras que el ensayo de la diabetes todav\u00eda tardar\u00e1 algo porque debemos estudiar la seguridad del tratamiento\u201d.<\/p>\n<p>Respecto al futuro de la terapia g\u00e9nica, F\u00e0tima Bosch cree que \u201caunque no empez\u00f3 con buen pie, se est\u00e1 empezando a salir del t\u00fanel. Mucha gente se est\u00e1 lanzando y empiezan a funcionar los ensayos cl\u00ednicos. Esto hace que las compa\u00f1\u00edas farmac\u00e9uticas que hace unos a\u00f1os se mostraban reacias a invertir, ahora est\u00e1n dispuestas a hacerlo\u201d.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La directora del Centro de Biotecnolog\u00eda Animal y Terapia G\u00e9nica de la Universidad Aut\u00f3noma de Barcelona, F\u00e0tima Bosch, ha explicado sus \u00faltimas aproximaciones a la terapia g\u00e9nica en una conferencia el 23 de marzo en el ciclo de seminarios del IDIBELL. El objetivo de la investigaci\u00f3n del centro que dirige Bosch es conocer muy bien [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":21380,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-17 16:39:47","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11334"}],"collection":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/comments?post=11334"}],"version-history":[{"count":3,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11334\/revisions"}],"predecessor-version":[{"id":21381,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/posts\/11334\/revisions\/21381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media\/21380"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/media?parent=11334"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/categories?post=11334"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/es\/wp-json\/wp\/v2\/tags?post=11334"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}